ICAAC 2011
BC-3781
Population Pharmacokinetic Analyses for BC-3781 Using Phase 2 Data
BC-3781
An Age and Gender Study Investigating the Safety, Tolerance and
Pharmacokinetics of BC-3781
Efficacy of BC-3781 in Murine Pneumonia Models
Determination of Disk Diffusion and MIC Quality Control Ranges for
BC-3781 using CLSI Multi-Laboratory M23-A3 Study Design
Activity of BC-3781, a Novel Pleuromutilin Compound, Tested against
Clinical Isolates of MRSA, Including Molecularly Characterized
Community-Acquired and Hospital-Associated Strains
Antimicrobial Activity of the Investigational Pleuromutilin BC-3781
Against Organisms Responsible for CA-RTI
In Vivo Pharmacodynamic Activity of BC-3781
Pre-clilnical Efficacy of BC-3781 in Thigh and Bacteremia Infections
Caused by Staphylococci
ECCMID 2010
BC-3781
Safety, Tolerance and Pharmacokinetics of Single and Repeat Doses of
BC-3781, a Novel Antimicrobial
In Vivo Pharmacodynamic Activity of BC-3781
Pharmacokinetics, Mass Balance and Tissue Distribution of [14C]-BC-3781
in Non-pigmented Rats
Antimicrobial Activity of the Investigational Pleuromutilin Compound
BC-3781 against Gram-positive Organisms Commonly Associated
with Cutaneous Infections
Correlation of In Vitro Susceptibility Testing Results for an
Investigational Pleuromutilin (BC-3781) Using MIC and Disk Diffusion
Methods Against Gram-Positive Pathogens
BC-3205
Disk Diffusion and MIC Quality Control Ranges for BC-3205 and BC-3781,
Novel Pleuromutilin Class Antimicrobials
Pharmacokinetics, Mass Balance and Tissue Distribution of [14C]-BC-3205
in Non-pigmented Rats
Activity of BC-3205 When Tested against a Collection of Gram-positive
Organism Responsible for Skin and Skin Structure Infections
Correlations of Broth Microdilution MIC and Disk Diffusion Results for an
Investigational Agent, BC-3205 Among Potentially Indicated Species
ICAAC 2009
BC-7013
In Vitro Antibacterial Spectrum of BC-7013, a Novel Peluromutilin
Derivative for Topical Use in Humans
BC-3205
In Vivo Pharmacodynamic Activity of BC-3205, a Novel Pleuromutilin
Derivative
In Vitro Antibacterial Spectrum of BC-3205, a Novel Pleuromutilin
Derivative for Oral Use in Humans
